WO2000068397A1 - Production de tagatose biologique par escherichia coli recombine - Google Patents

Production de tagatose biologique par escherichia coli recombine Download PDF

Info

Publication number
WO2000068397A1
WO2000068397A1 PCT/KR1999/000661 KR9900661W WO0068397A1 WO 2000068397 A1 WO2000068397 A1 WO 2000068397A1 KR 9900661 W KR9900661 W KR 9900661W WO 0068397 A1 WO0068397 A1 WO 0068397A1
Authority
WO
WIPO (PCT)
Prior art keywords
tagatose
coli
galactose
recombinant
arabinose isomerase
Prior art date
Application number
PCT/KR1999/000661
Other languages
English (en)
Inventor
Pil Kim
Hoe-Jin Roh
Sang-Hyun Yoon
Jin-Hwan Choi
Original Assignee
Tongyang Confectionery Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tongyang Confectionery Co. filed Critical Tongyang Confectionery Co.
Priority to AU10806/00A priority Critical patent/AU1080600A/en
Priority to EP99954465A priority patent/EP1095153A1/fr
Publication of WO2000068397A1 publication Critical patent/WO2000068397A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/24—Preparation of compounds containing saccharide radicals produced by the action of an isomerase, e.g. fructose

Definitions

  • the present invention relates to a novel recombinant E. coli, a fermentation process and a enzymatic conversion process for tagatose production using such recombinant E. ⁇ li harboring vector containing the gene of L-arabinose isomerase, and the promoter controlled artificially.
  • D-Tagatose is one of ketohexoses as well as one of D-galactose isomers. D-Tagatose is reported as the sweetener having the taste most similar to that of sucrose (92%). In addition, D-tagatose does not show laxative effect, which other polyols generally do. Due to such reasons, D-tagatose has been recently regarded as a non-caloric sweetener substituted by sucrose [Zehener, L. R., D-Tagatose as a low-calorie carbohydrate sugar and bulking agent, EP 257626 (1988) ; Marzur, A. W., Functional sugar substitutes with reduced calories, EP 341062 (1989)].
  • D-Galactose could be converted into D-tagatose in the presence of a calcium catalyst [Beadle, J. R., Saunders, J. P., and Wajda, T. J., Process for manufacturing tagatose, WO 92/12263 (1992)].
  • a calcium catalyst Beadle, J. R., Saunders, J. P., and Wajda, T. J., Process for manufacturing tagatose, WO 92/12263 (1992)
  • the chemical synthesis is economical, this process also requires disadvantageous high temperature and high pressure.
  • the biological process has been researched with interest as an environmentally clean process. As a consequence, the biological production of D-tagatose has been intensively studied recently.
  • L-arabinose isomerase (AraA) could convert galactose into tagatose.
  • Cheetham reported that L-arabinose isomerase from Mycobacterium and Lactobacillus catalyzes the conversion from D-galactose to D-tagatose as well as that of from L-arabinose to L-ribulose, because of the similar substrate configuration [Cheetham, P. S. J., and Wootton, A. N., "Byconversion of D-galactose into D-tagatose", Enzyme Microbiol. Technol, 15, 105-108 (1993)].
  • Enterobacter agglomerans could also produce tagatose from galactose during the growth on the arabinose pre-induced medium. Such implies the fact that arabinose isomerase could mediate the conversion of tagatose [Kim, S. Y., Roh, H. J., and Oh, D. K., "D-Tagatose production from D-galactose by Enterobacter agglomerans TY-25", Kor. ]. Appl. Microbiol. Biotechnol, 25, 490-494 (1997)].
  • the object of the present invention is to provide a recombinant E.coli having a new metabolic pathway for producing tagatose from galactose.
  • Another object of the present invention is to provide new method for tagatose production by using said recombinant E.coli.
  • the further object of the present invention is to provide a new method for tagatose production by using the L-arabinose isomerase originated from said recombinant E.coli.
  • the present invention relates to a recombinant E.coli (KCTC-0603BP) harboring vector comprising i ) the gene of L-arabinose isomerase (EC 5.3.1.4; araA) and ii ) the promoter controlled artificially (pTClOl) for tagatose production.
  • araA is originated from the group consisting of E.coli, Bacillus, Salmonella, Enterobacter, Klebsiella, Pseudomonas, Lactobacillus, Zymononas, Ghiconobacter, RJtizobium, Acetobacter, RJwdobacter, Agrobacterium, and other microorganisms. Further, araA is integrated into the host chromosome.
  • the another aspect of the present invention relates to a fermentation process for tagatose production wherein the medium comprises 10-300 g/L of galactose, 7-13 g/L of yeast extract, 2-4 g/L of KH 2 P0 4 5-7 g/L of Na 2 HP ⁇ 4 and 1-3 g/L of ammonium chloride.
  • L-arabinose isomerase from said strain mediates galactose to tagatose conversion.
  • the L-arabinose isomerase can be immobilized for the recycle.
  • the conversion medium comprises 10-500 g/L of galactose, 2-4 g/L of KH2PO 4 , and 5-7 g/L of Na 2 HP0 4 .
  • Fig. 1 is a chemical structure of D-tagatose and D-galactose.
  • Fig. 2 is a schematic diagram of bioconversion by L-arabinose isomerase.
  • Fig. 3 is a photograph which represents PCR product of L-arabinose isomerase from E.coli. Arrow indicates the PCR product of Ara A from E.coli (1.5 kb). Lane 1 shows the size marker (lkb DNA Ladder, NEB, USA).
  • Fig. 4 is a plasmid map of pTClOl, which harboring L-arabinose isomerase.
  • Fig. 5 is a photograph which represents EcoRl-Hindl ⁇ double digest of pTClOl. Arrow indicates the pTClOl. Lane 1 shows the size marker (lkb DNA Ladder, NEB, USA).
  • Fig. 6 is a profile of tagatose production by purified L-arabinose isomerase.
  • D-Tagatose is a potential bulking agent in food as a non-caloric sweetener.
  • plasmids harboring the L-arabinose isomerase gene (araA) from Esdierichia coli is constructed because L-arabinose isomerase has been suggested as an enzyme that mediates the bioconversion of galactose to tagatose as well as that of arabinose to ribulose.
  • the constructed plasmids has been named as pTClOl, which contains the araA from E.coli.
  • tagatose has been produced from galactose in 9.0—11.0 % yields.
  • the purified L-arabinose isomerase of E.coli with the plasmid pTClOl has also produced 25—35 g/L of tagatose from 100 g/L of galactose for 150 —180 hours bioconversion.
  • the enzyme extract of E.coli with the plasmid pTClOl has been immobilized into alginate bead. By using an immobilized enzyme system, 11 —14 g/L of tagatose has been produced from 10 % galactose for 24 hours.
  • E.coli is a Gram negative facultative anaerobic rod-form bacteria [Holt J. G., et. al, Bergey's Manual of Systematic Bacteriology 9th ed., 179, Williams & Wilkins (1994)]. It shows simple nutrient requirement, fast life cycle (about 20 min) in the optimal condition (pH 7.0, 37°C) [Stanier R. Y., et. al, The Microbiol World, 5th ed., 439 - 452(1986)].
  • E.coli is the most well known organism in physiology and genetics. Therefore, metabolism of E.coli can be easily controlled by the methods of genetic engineering and metabolic engineering.
  • the gene of L-arabinose isomerase (araA) of E.coli W3110 has been cloned by using a PCR technique, inserted into vector pKK223-3, which yields pTClOl.
  • the constructed plasmids harboring araA from E.coli has been used to transform E.coli JM105 (E.coli JM105/pTC101).
  • ImM IPTG was added to medium.
  • AraA L-Arabinose isomerase
  • the normal E.coli does not express AraA in the medium for tagatose production because the medium contains galactose as a sole carbon source.
  • the AraA could be artificially induced by adding an IPTG.
  • E.coli JM105/pTC101 was deposited in Korean Collection for Type Cultures in Korea Research Institute of Bioscience and Bioengineering, in accession number of KCTC-0603BP on April 26, 1999 under Budapest Treaty.
  • Step 1 PCR cloning of araA and Insertion into Expression Vector
  • the template for PCR of araA was chromosome of a wild type E.coli W3110 [Genetic stock center collection number (CGSC) 4474],
  • the each primer used in PCR contained the part of araA terminal sequence and restriction enzyme site (EcoRI and Hi ⁇ rflll, respectively).
  • FORWARD 5'-GACGAATTCATGACGATT-3' (SEQ ID NO. 1)
  • BACKWARD 5'-TGCAAGCTTTTAGCGACG-3' (SEQ ID NO. 2)
  • PCR product sequence (SEQ ID NO. 3) is as follows.
  • the constructed plasmid was transformed into E.coli JM105 [Roh, H. J., Kim, P., Park Y. C, and Choi, J. H., Biotechnol and Appl. Biochem., BA99/65, in press] (Fig.4).
  • Step 2 Strain Selection
  • the transformed strains were selected on the plate containing ampicillin (50g/ml) on the base of ampicillin-resistance. The colonies were further confirmed by restriction enzyme which digests the harbored plasmids, which shows 1.5 kb + 4.5 kb DNA fragments at the time of digestion by EcoRI and HmdIII (Fig. 5). The finally selected strain was named as E.coli JM105/pCT101, and said E.coli JM105/pTC101 was deposited in Korean Collection for Type Cultures in Korea Research Institute of Bioscience and Bioengineering, in accession number of KCTC-0603BP on April 26, 1999 under Budapest Treaty.
  • the E.coli JM105/pTC101 was pre-cultured in the LB-medium, and then transferred into main culture medium.
  • the main medium contained following components (Table 1).
  • Tagatose and galactose were estimated by using a HPLC (alliance 2690, Waters, USA) with RI detector (RID410, Waters, USA). The separation was made by C18-amine column (KR100-10NH 2 , Kromasil, Bohus, Sweden) eluted isocratically by 80% acetonitrile (35°C, 2 ml/min).
  • recombinant E.coli expressing L-arabinose isomerase could convert galactose into tagatose, where control strain could not.
  • a crude extract of AraA from E.coli was prepared as follows. Actively growing cells (50 ml, O.D. 600 2.0) in the LB-medium containing IPTG (1 mM) were prepared by centrifugation (7,000 g, 4°C). The cell pellet was resuspended in a 5 ml of phosphate buffer (50 mM, pH 7.0). The cells were disrupted by using an ultrasonic processor (50-watt Model, Cole-Parmer) at 40% output for 10 min in the ice. The crude arabinose isomerase solution was obtained after removal of cell-debris by centrifugation of the cell-disrupted suspension at 7,000 g and 4"C for 15 min.
  • a crude extract of AraA was fractionated by ammonium sulfate salting out at 40-60% saturation, and pelleted by centrifuge (10,000g, 4°C). The pellet was further dialyzed overnight at 4°C using a cellulose membrane tubing (MWCO : 12,000, Sigma, USA) to remove ammonium sulfate. Column chromatography was further carried out using DEAE (Sigma, USA) and Q-Sepharose (Sigma, USA) as anion exchange resins. The final purified L-arabinose isomerase showed 43 U/ml, where one unit defined as the amount of enzyme which produced 1 g-tagatose per minute at 35 °C, pH 7.0.
  • the reaction mixtures consisted of 9 ml of galactose (1 g) dissolved in 50mM phosphate buffer (pH 7.0) and 1 ml of enzyme solution mentioned the above.
  • the bioconversion for tagatose production was performed at 35 °C, pH 7.0 for 168 hrs. As shown in Fig. 6, the final tagatose concentration was reached 29.5 g/L. Remained galactose was 70.5 g/L.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La présente invention concerne un Escherichia coli recombiné et un procédé de production de D-tagatose. Plus particulièrement, cette invention concerne l'élaboration de E.coli recombiné hébergeant L-arabinose isomérase, la conversion de cellules entières de D-galactose en D-tagatose par E.coli recombiné exprimant L-arabinose isomérase, la production enzymatique de D-tagatose par l'extraction de E.coli recombiné exprimant L-arabinose isomérase, et la bioconversion par L-arabinose isomérase immobilisé.
PCT/KR1999/000661 1999-05-06 1999-11-04 Production de tagatose biologique par escherichia coli recombine WO2000068397A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU10806/00A AU1080600A (en) 1999-05-06 1999-11-04 Biological tagatose production by recombinant LTiGTescherichia coliLT/iGT
EP99954465A EP1095153A1 (fr) 1999-05-06 1999-11-04 Production de tagatose biologique par escherichia coli recombine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1999/16118 1999-05-06
KR19990016118A KR100309327B1 (ko) 1999-05-06 1999-05-06 아라비노스 이성화효소를 포함한 재조합 대장균주와 이를 이용한타가토스의 생산방법

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09743196 A-371-Of-International 2001-01-08
US10/440,407 Continuation US20030235894A1 (en) 1999-05-06 2003-05-19 Biological tagatose production by recombinant Escherichia coli

Publications (1)

Publication Number Publication Date
WO2000068397A1 true WO2000068397A1 (fr) 2000-11-16

Family

ID=19583888

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR1999/000661 WO2000068397A1 (fr) 1999-05-06 1999-11-04 Production de tagatose biologique par escherichia coli recombine

Country Status (4)

Country Link
EP (1) EP1095153A1 (fr)
KR (1) KR100309327B1 (fr)
AU (1) AU1080600A (fr)
WO (1) WO2000068397A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002052021A1 (fr) * 2000-12-22 2002-07-04 Yu Ryang Pyun L-arabinose isomerase thermostable et procede de preparation de d-tagatose a partir de celle-ci
WO2003008593A2 (fr) * 2001-07-16 2003-01-30 Bioteknologisk Institut Nouvelle isomerase thermostable et utilisation correspondante, notamment dans la production de tagatose
US7052898B2 (en) 2001-07-16 2006-05-30 Bioneer A/S Thermostable isomerase and use hereof, in particular for producing tagatose
EP2348107A2 (fr) 2003-02-18 2011-07-27 Metabolic Explorer Procédé de préparation de microorganismes évolués permettant la création ou la modification de voies métaboliques
US10570467B1 (en) 2016-09-27 2020-02-25 The Board Of Trustees Of The University Of Illinois Recombinant microorganisms for conversion of oligosaccharides into functional sweeteners
EP3578651A4 (fr) * 2016-12-23 2021-01-13 Kyungpook National University Industry-Academic Cooperation Foundation Souche recombinée ayant une voie métabolique du sucre modifiée et procédé de criblage de sucre isomérase l'utilisant

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100464061B1 (ko) * 2002-05-15 2004-12-30 (주)케비젠 아라비노스 이성화효소의 고정화에 의한 타가토스의 생산방법
US8137946B2 (en) 2006-11-27 2012-03-20 Cj Cheiljedang Corporation Recombinant GRAS strains expressing thermophilic arabinose isomerase as an active form and method of preparing food grade tagatose by using the same
KR20100001209A (ko) * 2008-06-26 2010-01-06 한국화학연구원 갈락토오스 이용이 억제된 미생물을 이용한 타가토오즈제조방법
KR101015343B1 (ko) 2008-08-05 2011-02-16 씨제이제일제당 (주) 효소 활성이 향상된 아라비노스 이성화효소 변이체

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0552894A2 (fr) * 1992-01-16 1993-07-28 Kraft Foods, Inc. Préparation de D-Tagatose par isomérisation enzymatique de D-galactose
JPH06113875A (ja) * 1992-10-08 1994-04-26 Hayashibara Biochem Lab Inc Ｌ−ガラクトースの製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0552894A2 (fr) * 1992-01-16 1993-07-28 Kraft Foods, Inc. Préparation de D-Tagatose par isomérisation enzymatique de D-galactose
JPH06113875A (ja) * 1992-10-08 1994-04-26 Hayashibara Biochem Lab Inc Ｌ−ガラクトースの製造方法

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 107, no. 3, 20 July 1987, Columbus, Ohio, US; abstract no. 18593H, LEE ET AL.: "The organization of the araBAD operon of escherichia coli" page 162; XP002940777 *
CHEMICAL ABSTRACTS, vol. 121, no. 11, 12 September 1994, Columbus, Ohio, US; abstract no. 132405N, IKUMOR ET AL.: "Manufacture of L-galactose with D-arabinose isomerase" page 878; XP002940779 *
CHEMICAL ABSTRACTS, vol. 129, no. 19, 9 November 1998, Columbus, Ohio, US; abstract no. 244169K, OIH ET AL.: "Optimization of culture conditions for D-gatatose production from D-galactose by enterobacter agglomerans" page 596; XP002940778 *
GENE, vol. 47, no. 2-3, 1986, (ENG.), pages 231 - 244 *
SANOP MISAENGMUL HAKHOECHI, vol. 26, no. 3, 1998, (KORICAN), pages 250 - 260 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002052021A1 (fr) * 2000-12-22 2002-07-04 Yu Ryang Pyun L-arabinose isomerase thermostable et procede de preparation de d-tagatose a partir de celle-ci
WO2003008593A2 (fr) * 2001-07-16 2003-01-30 Bioteknologisk Institut Nouvelle isomerase thermostable et utilisation correspondante, notamment dans la production de tagatose
WO2003008593A3 (fr) * 2001-07-16 2003-10-30 Bioteknologisk Inst Nouvelle isomerase thermostable et utilisation correspondante, notamment dans la production de tagatose
US7052898B2 (en) 2001-07-16 2006-05-30 Bioneer A/S Thermostable isomerase and use hereof, in particular for producing tagatose
EP2348107A2 (fr) 2003-02-18 2011-07-27 Metabolic Explorer Procédé de préparation de microorganismes évolués permettant la création ou la modification de voies métaboliques
US10570467B1 (en) 2016-09-27 2020-02-25 The Board Of Trustees Of The University Of Illinois Recombinant microorganisms for conversion of oligosaccharides into functional sweeteners
EP3578651A4 (fr) * 2016-12-23 2021-01-13 Kyungpook National University Industry-Academic Cooperation Foundation Souche recombinée ayant une voie métabolique du sucre modifiée et procédé de criblage de sucre isomérase l'utilisant

Also Published As

Publication number Publication date
KR100309327B1 (ko) 2001-09-29
AU1080600A (en) 2000-11-21
EP1095153A1 (fr) 2001-05-02
KR20000073075A (ko) 2000-12-05

Similar Documents

Publication Publication Date Title
US8216818B2 (en) Ketose 3-epimerase, its preparation and uses
TWI682998B (zh) 用於生產塔格糖的組成物及利用其生產塔格糖的方法
CA2653028C (fr) Procede de fabrication enzymatique d'acides 2-hydroxy-2-methylcarboxyliques
Roh et al. Bioconversion of D‐galactose into D‐tagatose by expression of L‐arabinose isomerase
JP2020511986A (ja) タガトース生産用組成物及びこれを用いたタガトースの製造方法
JP2020511974A (ja) タガトース生産用組成物及びこれを用いたタガトースの製造方法
EP1095153A1 (fr) Production de tagatose biologique par escherichia coli recombine
KR102044957B1 (ko) 사이코스의 제조방법
USRE29692E (en) Process of preparing glucose isomerase
CN111411066B (zh) 一种双途径复合产神经氨酸枯草芽孢杆菌及构建方法
JP2000295994A (ja) キシリトールの製造法
EP0251489A2 (fr) Procédé pour produire de l'acide 5'-guanilique
US20030235894A1 (en) Biological tagatose production by recombinant Escherichia coli
US8852891B2 (en) N-acetylglucosamine-2-epimerase and method for producing CMP-neuraminic acid using the same
WO2002072841A1 (fr) Adn codant pour une hydantoinase, adn codant pour une hydrolase d'acide amine l carbamyle, adn recombinant, cellules transformees, procede de production de proteine et procede de production d'acide amine optiquement actif
NO139691B (no) Fremgangsmaate for fremstilling av glukoseisomeriserende enzym fra mikroorganismer
JPH08263A (ja) マルトースをトレハロースに変換する組換え型酵素
KR100464061B1 (ko) 아라비노스 이성화효소의 고정화에 의한 타가토스의 생산방법
KR100821377B1 (ko) 내열성 아라비노오스 이성화효소 활성을 갖는 신규한지오바실러스 더모디니트리피컨스 CBG-Al 균주, 그 효소 및타가토오스의 생산방법
CN113493760B (zh) 一种生物合成2-苯乙醇的谷氨酸棒杆菌、构建方法及应用
EP1121446A1 (fr) Aminoacylase et son utilisation pour la preparation de d-acides amines
JP4439153B2 (ja) 耐熱性マンノースイソメラーゼ及び該酵素を用いたマンノースの製造法
CN115261350A (zh) 一种淀粉蔗糖酶的突变体及其在生产α-熊果苷中的应用
CN116064346A (zh) 一种高效合成乳糖的方法及其应用
CN116426501A (zh) 一种gdp-d-甘露糖水解酶突变体及其应用

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 09743196

Country of ref document: US

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1999954465

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999954465

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999954465

Country of ref document: EP